核出口抑制剂塞利尼克索尔改善了小鼠焦点细分结核硬化模型中的功能
Yingying Gao1, Mohamed Hamed2, Ina Verena Martin1
1Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany.
American journal of physiology. Renal physiology
|September 2, 2025
概括
在焦点分片结核病 (FSGS) 鼠标模型中,Selinexor (KPT-330) 改善了功能和高脂血症. 然而,该药物并没有阻止脏损伤的进展.
科学领域:
- 肝脏病学
- 分子生物学
- 药理学
背景情况:
- 焦点细分结核硬化 (FSGS) 是导致功能衰竭的主要原因,通常涉及细胞损伤.
- 核毛孔综合体 (NPC) 功能障碍与受体损伤有关,但治疗点仍未得到充分研究.
- 塞林克索 (KPT-330) 抑制XPO1介导的输出,可能恢复NPC功能.
研究的目的:
- 在自发性FSGS的小鼠模型中研究selinexor (KPT-330) 的治疗潜力.
- 评估KPT-330对功能,脂质概况和FSGS组织损伤的影响.
主要方法:
- 使用HeLa细胞证实了KPT-330对NPC功能的影响.
- 用KPT-330治疗自发FSGS的慕尼黑WistarFroemter (MWF) 大鼠进行了10周的治疗.
- 评估了功能 (血清肌素,囊素C),脂质水平和组织学.
主要成果:
- 治疗KPT-330显著降低了血清中的肌素和囊素C水平.
- 治疗后高脂血症,包括甘油三和总胆固醇显著降低.
- 尽管功能有所改善,但组织学参数显示血球硬化和细胞损伤的持续进展.
结论:
- 在FSGS大鼠模型中,Selinexor (KPT-330) 对功能和脂质代谢具有有益作用.
- KPT-330恢复NPC功能的能力为细胞相关脏疾病提供了潜在的治疗途径.
- 药物在阻止FSGS组织进展方面的有效性需要进一步研究.
相关概念视频
Nephrotic Syndrome I : Introduction
1.0K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.0K
Serum Studies: Renal Function Tests
643
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
643


